Clinical Trial Update: Effect of Atorvastatin on the Frequency of Ventilator-associated Pneumonia in Patients With Ischemic Stroke [EARLY_Phase 1]

View source ↗

Summary

Early-phase clinical trial evaluating whether atorvastatin reduces ventilator-associated pneumonia in patients with ischemic stroke.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke
• Ventilator-associated Pneumonia

Drugs mentioned

• atorvastatin (atorvastatin)

Snippet

Sponsor: Shanghai Minhang Central Hospital | Conditions: Ventilator-associated Pneumonia, Ischemic Stroke | EARLY_Phase 1 | Status: UNKNOWN